Study on the Interaction between Gatifloxacin Mesylate and Salmon Sperm DNA by Fluorescence Method

The interaction between gatifloxacin mesylate (GM) and salmon sperm DNA was studied by fluorescence spectrometry and ultra‐violet (UV) spectrometry. Additions of salmon sperm DNA to GM solution resulted in its strong fluorescence quenching and UV absorbance decrease due to the strong interaction between GM and salmon sperm DNA. Both the maximum fluorescence emission wavelength and the maximum UV absorbance wavelength of GM did not change with the increasing concentration of salmon sperm DNA, indicating no intercalative binding existed between them. The Stern‐Volmer plot indicated that the fluorescence‐quenching constant at different temperatures or different salmon sperm DNA concentration ranges was different. Effects of ionic strength and I^? on the fluorescence quenching of GM by salmon sperm DNA indicated that electrostatic interaction and groove binding coexisted between them.     

甲磺酸多沙唑嗪的合成

甲磺酸多沙唑嗪(doxazosin mesylate,Ⅰ)的化学名为1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-4-(1,4-苯骈二恶烷-2-甲酰基)哌嗪甲磺酸盐,是一种新型的高选择性α1受体阻滞剂[1],半衰期长,且有明显的降压和降脂作用,同时对单纯性前列腺增生引起的排尿困难具有良好的作用.目前已成为国内外治疗轻中度高血压的一线药物[2,3,4].     

Nonaqueous capillary electrophoresis of imatinib mesylate and related substances

In the present study, nonaqueous capillary electrophoretic separation of imatinib mesylate (IM) and related substances, N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinamine (PYA), N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((piperazin-1-yl)methyl) benzamide (NDI) and 4-chloromethyl-N-(4-methyl-3-((4-(pyridin-3-yl) pyrimidin-2-yl) amino) phenyl) benzamide (CPB) was developed. The influential factors affecting separation, including type and concentration of the electrolyte, applied voltage, and buffer modifier were investigated. Baseline separation of the studied analytes was obtained using a buffer of 50 mM Tris and 50 mM methanesulfonic acid in methanol at a apparent pH (pH*) of 1.65. To enhance the sensitivity, large-volume sample stacking was employed for online concentration. The strongest analytical signal with a suitable separation was achieved when the injection time was 100 s. The linearity ranges of PYA and NDI were 0.100-2.50 μg mL(-1) , and that of CPB was 0.125-2.50 μg mL(-1) , with good coefficients (r(2) > 0.9948). The relative standard deviations of intra- and interday were satisfactory. Under the optimized conditions, seven batches of the synthesized samples were analyzed and CPB was detected in two batches. Owing to its simplicity, effectiveness, and low price, the developed method is promising for quality control of IM.     

甲磺酸培氟沙星与人血清白蛋白之间结合模式的研究

采用实验和计算的方法研究了甲磺酸培氟沙星与人血清白蛋白之间的结合作用.荧光法测得甲磺酸培氟沙星与人血清白蛋白形成一种类型的复合物,结合常数为1.7×10⁵ L&;#8226;mol^－1,有1.05个平均结合位点；微量热法测得该药物-蛋白结合过程中焓变为1.03 kJ&;#8226;mol^－1,熵变为101.28 J&;#8226;K^－1&;#8226;mol^－1,反应为熵驱动.用分子对接的方法预测了甲磺酸培氟沙星与人血清白蛋白的结合模式.计算表明,甲磺酸培氟沙星可结合在人血清白蛋白的两个药物结合位点,疏水作用即熵效应在药物与蛋白的结合中起重要作用,预测的结合自由能和实验值基本一致.     

荧光法研究喹诺酮类抗菌药物和蛋白质的相互作用

用荧光光谱法、分光光度法研究水溶液中甲磺酸培氟沙星、盐酸芦氟沙星与牛血清白蛋白(BSA)的相互结合反应,表明二者以摩尔比1∶1牢固结合,结合的平衡常数分别为KPM=7 3×104L mol、KRH=9 3×104L mol。根据F rster非辐射能量转移机理,求算了甲磺酸培氟沙星、盐酸芦氟沙星与牛血清白蛋白给体-受体间距离r分别为2 82nm,2 93nm,能量转移效率E分别为0 31,0 44。喹诺酮类药物与牛血清白蛋白的相互结合作用为单一的静态猝灭过程,其作用机制为能量转移机制。     

Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designs

A simple high performance liquid chromatographic method for the determination of process-related impurities in bulk drug of the central anticholinergic compound pridinol mesylate, has been developed and validated. Spectroscopically characterized synthetic impurities were used as standards. The chromatographic separation was optimized employing an experimental design strategy, and was achieved on a C₁₈ column with a mobile phase containing 50 mM potassium phosphate buffer (pH 6.4), MeOH and 2-propanol (20:69:11, v/v/v), delivered at a flow rate of 1.0 mL min⁻¹. UV detection was performed at 245 nm. The optimized method was thoroughly validated, demonstrating to be selective, when the chromatogram was recorded with a diode-array detector and peak purities were evaluated (>0.9995). The method is robust and linear (r² > 0.99) over the range 0.05-2.5% (5-250% with regards to the 1% specification limit for both process-related impurities); it is also precise, regarding repeatability (RSD ≤ 1.5% for all of the analytes) and intermediate precision aspects and LOQ values for the impurities are below 0.01%. Method accuracy, evidenced by low bias of the results and analyte recoveries in the range of 99.1-102.7%, was assessed at five analyte concentration levels. The usefulness of the determination was also demonstrated through the analysis of different lots of pridinol mesylate bulk substance. The results indicate that the method is suitable for the quality control of the bulk manufacturing of pridinol mesylate drug substance.     

Recent advancement and development of chitin and chitosan-based nanocomposite for drug delivery: Critical approach to clinical research

This review depicts the exposure of chitin and chitosan base multifunctional nanomaterial composites for promising applications in field of biomedical science structure, synthesis as well as potential application from a colossal angle. We elaborated critically each of the chitin and chitosan base nanomaterial with its potential application toward biomedical science. For different biomedical applications it use in form of hydrogels, microsphere, nanoparticles, aerogels, microsphere and in form of scaffold. Due to this it had been blended with different polymer such as starch, cellulose, alginate, lipid, hyaluronic acid, polyvinyl alcohol and caboxymethyl cellulose. In this review article, a comprehensive overview of combination of chitin and chitosan base nanomaterial with natural as well as synthetic polymers and their biomedical applications in biomedical field involving drug delivery system all the technical scientific issues have been addressed; highlighting the recent advancements.     

甲磺酸帕珠沙星与牛血清白蛋白相互作用及共存金属离子的影响

用荧光光谱法研究水溶液中甲磺酸帕珠沙星与牛血清白蛋白的结合反应,测定了298,308K温度下甲磺酸帕殊沙星与牛血清白蛋白的结合常数KA（分别为7．63×10^4,6．25×10^4 L·mol^-1）和结合位点数n（分剐为1．04,1．03）,探讨了其荧光猝灭机制;根据热力学参数确定了甲磺酸帕珠沙星与牛血清白蛋白之间的作用力以静电作用为主,并运用Foster偶极-偶极非辐射能量转移原理,测定了其相互结合时授-受体间距离r为3．17nm;采用同步荧光技术确定甲磺酸帕珠沙星对牛血清白蛋白构象产生一定的影响;进一步考察了3种金属离子对该结合反应的影响,探讨了其相互作用机制．     

Structural elucidation of gemifloxacin mesylate degradation product

Gemifloxacin mesylate (GFM), chemically (R,S)‐7‐[(4Z)‐3‐(aminomethyl)‐4‐(methoxyimino)‐1‐pyrrolidinyl]‐1‐cyclopropyl‐6‐fluoro‐1,4‐dihydro‐4‐oxo‐1,8‐naphthyridine‐3‐carboxylic acid methanesulfonate, is a synthetic broad‐spectrum antibacterial agent. Although many papers have been published in the literature describing the stability of fluorquinolones, little is known about the degradation products of GFM. Forced degradation studies of GFM were performed using radiation (UV‐A), acid (1 mol L^?1 HCl) and alkaline conditions (0.2 mol L^?1 NaOH). The main degradation product, formed under alkaline conditions, was isolated using semi‐preparative LC and structurally elucidated by nuclear magnetic resonance (proton – ¹H; carbon – ¹³C; correlate spectroscopy – COSY; heteronuclear single quantum coherence – HSQC; heteronuclear multiple‐bond correlation – HMBC; spectroscopy – infrared, atomic emission and mass spectrometry techniques). The degradation product isolated was characterized as sodium 7‐amino‐1‐pyrrolidinyl‐1‐cyclopropyl‐6‐fluoro‐1,4‐dihydro‐4‐oxo‐1,8‐naphthyridine‐3‐carboxylate, which was formed by loss of the 3‐(aminomethyl)‐4‐(methoxyimino)‐1‐pyrrolidinyl ring and formation of the sodium carboxylate. The structural characterization of the degradation product was very important to understand the degradation mechanism of the GFM under alkaline conditions. In addition, the results highlight the importance of appropriate protection against hydrolysis and UV radiation during the drug‐development process, storage, handling and quality control. Copyright © 2015 John Wiley & Sons, Ltd.     

Benztropine mesylate: crystal structure and kinetics of dehydration

The crystal structure of benztropine mesylate has been determined. It is orthorhombic, Pbca, with a = 12. 885(8)Å, b = 32.012(9)Å, and c = 10.027(3) Å. It exhibits similar packing to that seen in the previously reported crystal structure of benztropine mesylate monhydrate. X-ray powder diffraction patterns have been used to identify the anhydrous and monohydrate forms. The dehydration of the monohydrate follows a first-order reaction mechanism with activation energy of 92(8) kJ mol^–1.